Psychiatric Manifestations of Body Dysmorphic Disorder 

  • Author: Iqbal Ahmed, MBBS, FRCPsych (UK); Chief Editor: David Bienenfeld, MD   more...
 
Updated: Feb 11, 2011
 

Background

Body dysmorphic disorder (BDD) is a relatively common and often severe psychiatric illness that is likely underrecognized and underreported. It is classified as a somatoform disorder in DSM-IV-TR; however, some authors have argued that it may be considered as part of the obsessive-compulsive or psychotic disorder spectrum.[1] The essential feature of this disorder is a preoccupation with an imagined defect in appearance or disproportionate concern with a slight physical anomaly. These preoccupations most often involve the nose, ears, face, hair, or features related to sexuality (such as breasts in women or muscular build or penis size in men), yet any body part may occupy the patient’s focus. By definition, body dysmorphic disorder causes significant distress or impairment in social, occupational, or other areas of functioning.[2]

Data suggest that quality of life and psychosocial functioning is as poor as, or poorer than, in those with obsessive-compulsive disorder (OCD).[3] BDD is associated with high rates of hospitalization (48%), and high rates of suicidal ideation and attempts.[4, 5] A history of suicidal ideation attributed primarily to BDD is reported in 45-70% of those with BDD, and past suicide attempts are reported in 22-24%.[6]

BDD affects 1-2% of the general population, making it more common than schizophrenia and bipolar disorder, and its prevalence has been reported to be as high as 7-15% in those undergoing cosmetic surgery.[7, 8, 9, 10] Persons with BDD who choose to undergo plastic surgery are generally unhappy with the results, and later often become concerned with another body part. They are often consumed with thoughts about the postoperative site. Surgeons and dermatologists have occasionally been victims of violence, even murder, by patients with BDD who are in despair over their procedural outcomes.[11]

The researcher Morselli first documented body dysmorphic disorder in 1886. Freud famously treated a patient who would likely today be diagnosed with body dysmorphic disorder. Freud nicknamed this patient "Wolf Man" in his writings to protect the identity of Sergei Pankejeff, the Russian aristocrat he was treating, who was so preoccupied with his nose that it significantly impaired his functioning.

Body dysmorphic disorder was originally called dysmorphophobia and was first included parenthetically as an example of an atypical somatoform disorder in the DSM-III. It was not until the release of DSM-III-R in 1987, that it was renamed body dysmorphic disorder. The DSM-IV-TR currently classifies it under the somatoform disorders. However, the DSM-V work group has recommended that BDD be reclassified from somatoform disorders to anxiety and obsessive-compulsive spectrum disorders, likely reflecting its similarities in both pathophysiology and treatment to OCD.

Per DSM-IV-TR criteria, body dysmorphic disorder is defined as the following:

A. Preoccupation with an imagined defect in appearance. If a slight physical anomaly is present, the person's concern is markedly excessive.

B. The preoccupation causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.

C. The preoccupation is not better accounted for by another mental disorder (eg, dissatisfaction with body shape and size in anorexia nervosa).

BDD usually appears during early adolescence, and, when left untreated, is often a chronic condition. Social values and mass media greatly influence body image, and, in turn, self-image. Most people have concerns related to appearance; however, this concern is considered pathologic when it causes distress that interferes with social or occupational functioning.

Case study

Ms. X, a 33-year-old single white female, presents with preoccupation focused on her "sparse" hair and "hideous" nose. She began worrying excessively about her appearance in her middle school years, focusing at that time on her acne and "extremely wide" forehead. She found her preoccupations very distressing but was too embarrassed to reveal this to family or friends. Although friends found her appearance normal, she was utterly convinced there was a problem. She generally spent 4-5 hours per day thinking about her perceived defect, carefully comparing her face to others, compulsively grooming herself, and checking herself in a mirror repetitively.

Due to her preoccupation she missed 1-2 days of work per week, and it prevented her from going out with friends or going on a date. She felt so distressed by her problem that she contemplated suicide. She then had 2 rhinoplasties done by a plastic surgeon to her specifications to fix her perceived nasal defect. However, she felt that her nose looked no better and she continued to be distressed by her appearance. She was seeking psychiatric help for her depression, which she related to her perceived defects.

Next

Pathophysiology

Although our understanding of the pathophysiology of body dysmorphic disorder is limited, it remains a subject of continuing research. A more robust understanding of BDD’s pathophysiology will surely inform and improve available treatment options. Recent studies highlight a variety of plausible etiological mechanisms, including such hypotheses as abnormal visual processing and hypo-NMDAR signal transduction.[12, 13]

Based on its pattern of heritability, genetic factors are suspected to play a causal role in the development of BDD. Family members of a patient diagnosed with BDD show a prevalence rate of BDD that is 4-8 times that found in the general population. There is also a heritable association of BDD in patients with OCD. Unfortunately, to date there is a dearth of studies that could more fully illuminate the molecular genetic etiology of BDD.[14]

In 2000, Deckersbach et al found that patients with body dysmorphic disorder had impaired verbal and nonverbal memory encoding strategies.[15] This finding suggests an involvement of executive memory deficits with a lesion of the frontostriatal connections. A similar abnormality in memory encoding also occurs in patients with OCD. Additionally, enlarged white matter volume and asymmetry of the caudate nucleus, favoring the left side, have been observed in patients with body dysmorphic disorder.

A study published in 2007 by Dr. Jamie Feusner has suggested that in body dysmorphic disorder, fundamental differences occur in the visual processing of faces. Katharine Phillips, MD, a professor of psychiatry at Brown University and prominent BDD researcher, has stated, "Dr. Feusner's study is groundbreaking."[15] The study also found that subjects with BDD had greater left hemisphere activation and may possess a cognitive style that relies more heavily on extraction and processing of details. Feusner and colleagues explain the implications of these functional neuroimaging findings:

“BDD patients may process faces in a piecemeal manner, while healthy controls’ perception of faces may be more configural and holistic. These laterality patterns in the BDD participants suggest a bias for local, or detail oriented, processing of faces over global processing.”[14]

Several studies have explored the causal role for disruptions in serotonergic transmission. Many of these are based on evidence that illustrates the effectiveness of SSRIs in the treatment of BDD. Overall, the exact role for serotonergic transmission in the etiology of BDD remains the subject of continuing research.[14]

In addition to the neuroanatomical, neurochemical, and genetic models of causality in BDD, several cognitive-behavioral models have been developed to explain BDD. While it is recognized that most people find at least 1 aspect of their appearance in which they are unsatisfied, people with BDD obsess on these perceived defects. These individuals are believed to use maladaptive cognitive processes that overemphasize the importance of perceived attractiveness. Following this logic, individuals with BDD, placing a disproportionate emphasis on physical attractiveness, view themselves negatively, experiencing low self-esteem, anxiety, shame, and sadness. These individuals use maladaptive coping methods such as mirror-gazing or avoidance.[16]

Previous
Next

Epidemiology

Frequency

United States

Body dysmorphic disorder affects 1-2% of the general population. Since it is underdiagnosed, this may be an underestimate. Patients underreport to their physicians because of intense shame. Prevalence in patients undergoing plastic or cosmetic surgery ranges from 7-15%.[10]

International

Incidence and prevalence are unknown with any precision or accuracy.

Mortality/Morbidity

Many patients affected with body dysmorphic disorder have comorbid conditions such as obsessive-compulsive disorder (OCD), major depression, delusions, or social phobia. Of those with a primary diagnosis of body dysmorphic disorder, 30% meet criteria for OCD.

Major depression is a common comorbidity; 60% of patients with BDD have major depression. Patients with BDD often have major depression as a result of body dysmorphic disorder. These patients also are at increased risk for suicide. Suicidal ideation attributed primarily to BDD is reported in 45-70% of those with BDD, and past suicide attempts are reported in 22-24%.[6] The annual rate of completed suicide (preliminary data based on 1 pilot study) in BDD is alarmingly high, at 0.3%.[6]

Because of frequent comorbidity with other conditions, the diagnosis of body dysmorphic disorder is often overlooked. In a study of 110 patients with body dysmorphic disorder, 51% did not reveal their symptoms to their therapist.

Because patients with body dysmorphic disorder have many features in common with OCD, body dysmorphic disorder has often been included in the spectrum of OCD. Similarities include repetitive thoughts of a perceived defect and activities centered on concealing or confirming the perceived deformity that consume most of the patient's time. Compared with OCD, body dysmorphic disorder has much higher rates of poor insight, ideas of reference, overvalued ideas, and delusions.

Social phobia is another common comorbid disorder found in those with body dysmorphic disorder.

Race

No data are available on the relationship between body dysmorphic disorder and race. However, one may speculate that cultures and groups with high emphasis on physical beauty and attractiveness may be more prone to having this disorder.

Sex

Body dysmorphic disorder affects men and women with near equal frequency. Female to male ratios are in the range of 1:1 to 3:2.[17]

Women more often have comorbid anxiety and panic disorder and are obsessed with legs and breasts.

Men are more likely to become preoccupied with the muscle size, described as "muscle dysmorphia" and considered as a subcategory of body dysmorphic disorder.[18] The disorder affects mostly men, particularly those who engage in weight lifting or body building. Men are also more likely to have a diagnosis of substance abuse (50%) and be single.

Age

The onset of body dysmorphic disorder is in adolescence and young adulthood. As mentioned by Philips and Kaye, the average age of onset is 16-17 years.[19] As with OCD, the course of body dysmorphic disorder is generally chronic. It may also occur in older adults who are overly concerned with their aging appearance.

Previous
 
 
Contributor Information and Disclosures
Author

Iqbal Ahmed, MBBS, FRCPsych (UK)  Faculty, Department of Psychiatry, Tripler Army Medical Center; Clinical Professor of Psychiatry, Clinical Professor of Geriatric Medicine, University of Hawaii, John A Burns School of Medicine

Iqbal Ahmed, MBBS, FRCPsych (UK) is a member of the following medical societies: Academy of Psychosomatic Medicine, American Association for Geriatric Psychiatry, American Neuropsychiatric Association, American Psychiatric Association, American Society of Clinical Psychopharmacology, and Royal College of Psychiatrists

Disclosure: Nothing to disclose.

Coauthor(s)

Lawrence Genen, MD, MBA  Child & Adolescent Psychiatry Fellow, Division of Child & Adolescent Psychiatry, Department of Psychiatry, Keck School of Medicine, University of Southern California

Disclosure: Nothing to disclose.

Thomas Cook, MD  Resident Physician, Department of Psychiatry, University of Hawaii, John A Burns School of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Denis F Darko, MD  Executive Director, Clinical Research and Development, Global Neuroscience, AstraZeneca

Denis F Darko, MD is a member of the following medical societies: American College of Physicians and American Psychiatric Association

Disclosure: AstraZeneca Salary Management position

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Harold H Harsch, MD  Program Director of Geropsychiatry, Department of Geriatrics/Gerontology, Associate Professor, Department of Psychiatry and Department of Medicine, Froedtert Hospital, Medical College of Wisconsin

Harold H Harsch, MD is a member of the following medical societies: American Psychiatric Association

Disclosure: lilly Honoraria Speaking and teaching; Forest Labs None None; Pfizer Grant/research funds Speaking and teaching; Northstar None None; Novartis Grant/research funds research; Pfizer Honoraria Speaking and teaching; Sunovion Speaking and teaching; Otsuke Grant/research funds reseach; GlaxoSmithKline Grant/research funds research; Merck Honoraria Speaking and teaching

Chief Editor

David Bienenfeld, MD  Professor of Psychiatry, Vice-Chair and Director of Residency Training, Department of Psychiatry, Wright State University, Boonshoft School of Medicine

David Bienenfeld, MD is a member of the following medical societies: American Medical Association, American Psychiatric Association, and Association for Academic Psychiatry

Disclosure: Nothing to disclose.

References
  1. Castle DJ, Rossell SL. An update on body dysmorphic disorder. Curr Opin Psychiatry. Jan 2006;19(1):74-8. [Medline].

  2. Phillips KA, Menard W, Fay C, Pagano ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. Jul-Aug 2005;46(4):254-60. [Medline]. [Full Text].

  3. Didie ER, Walters MM, Pinto A, Menard W, Eisen JL, Mancebo M, et al. A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder. Ann Clin Psychiatry. Jul-Sep 2007;19(3):181-6. [Medline].

  4. Phillips KA, Diaz SF. Gender differences in body dysmorphic disorder. J Nerv Ment Dis. Sep 1997;185(9):570-7. [Medline].

  5. Phillips KA, Menard W, Fay C. Gender similarities and differences in 200 individuals with body dysmorphic disorder. Compr Psychiatry. Mar-Apr 2006;47(2):77-87. [Medline]. [Full Text].

  6. Phillips KA, Menard W. Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry. Jul 2006;163(7):1280-2. [Medline]. [Full Text].

  7. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry. Dec 2001;158(12):2061-3. [Medline].

  8. Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, Brähler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med. Jun 2006;36(6):877-85. [Medline].

  9. Koran LM, Abujaoude E, Large MD, Serpe RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. Apr 2008;13(4):316-22. [Medline].

  10. Haas CF. Champion A. Secor D. Motivating factors for seeking cosmetic surgery: a synthesis of the literature. Plastic Surgical Nursing. Oct-Dec 2008;28(4):177-82. [Medline].

  11. Phillips KA. Body dysmorphic disorder: the distress of imagined ugliness. Am J Psychiatry. Sep 1991;148(9):1138-49. [Medline].

  12. Cleveland WL, DeLaPaz RL, Fawwaz RA, Challop RS. High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. Neural Plast. 2009;2009:768398. [Medline].

  13. Feusner JD, Moody T, Hembacher E, Townsend J, McKinley M, Moller H. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatry. Feb 2010;67(2):197-205. [Medline].

  14. Feusner JD, Yaryura-Tobias J, Saxena S. The pathophysiology of body dysmorphic disorder. Body Image. Mar 2008;5(1):3-12. [Medline].

  15. Deckersbach T, Savage CR, Phillips KA. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc. Sep 2000;6(6):673-81. [Medline].

  16. Buhlmann U, Teachman BA, Naumann E, Fehlinger T, Rief W. The meaning of beauty: implicit and explicit self-esteem and attractiveness beliefs in body dysmorphic disorder. J Anxiety Disord. Jun 2009;23(5):694-702. [Medline].

  17. Phillips KA, Didie ER, Feusner J, Wilhelm S. Body dysmorphic disorder: treating an underrecognized disorder. Am J Psychiatry. Sep 2008;165(9):1111-8. [Medline]. [Full Text].

  18. Grieve FG. A conceptual model of factors contributing to the development of muscle dysmorphia. Eat Disord. Jan-Feb 2007;15(1):63-80. [Medline].

  19. Phillips KA, Kaye WH. The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder. CNS Spectr. May 2007;12(5):347-58. [Medline].

  20. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33(1):17-22. [Medline].

  21. Butler Hospital. Butler Hospital Screening Questionnaire for Adolescents: Do I have BDD. Butler Hospital. Available at http://www.butler.org/body.cfm?id=237. Accessed 6.6.10.

  22. Yutzy, SParish, B. Somatoform Disorders. In: Tasman, A, Kay, J, Lieberman, J, First, M, Maj, M. Psychiatry. 2. Third. London: John Wiley & Sons; 2008:1538-1542/74.

  23. Didie ER, Kuniega-Pietrzak T, Phillips KA. Body image in patients with body dysmorphic disorder: evaluations of and investment in appearance, health/illness, and fitness. Body Image. Jan 2010;7(1):66-9. [Medline].

  24. Ravindran AV, da Silva TL, Ravindran LN, Richter MA, Rector NA. Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments. Can J Psychiatry. May 2009;54(5):331-43. [Medline].

  25. Phillips KA. Body dysmorphic disorder: clinical aspects and treatment strategies. Bull Menninger Clin. Fall 1998;62(4 Suppl A):A33-48. [Medline].

  26. [Guideline] National Collaborating Centre for Mental Health. Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder. London (UK): British Psychological Society, Royal College of Psychiatrists; 2006. 350 p. (National clinical practice guideline; no. 31).

  27. Crerand CE, Infield AL, Sarwer DB. Psychological considerations in cosmetic breast augmentation. Plast Surg Nurs. Jul-Sep 2007;27(3):146-54. [Medline].

  28. Arehart-Treichel J. Do Abnormal Visual Processes Underlie Body Dysmorphic Disorder?. Psychiatric News. January 18, 2008;Volume 43, Number 2Eating Disorders Centerhttp://www.emedicinehealth.com/collections/CO1589.aspDepression Centerhttp://www.emedicinehealth.com/collections/CO1588.aspAnorexia Nervosa Overviewhttp://www.emedicinehealth.com/articles/12688-1.aspDepression Overviewhttp://www.emedicinehealth.com/articles/10289-1.asp: 29. Available at http://pn.psychiatryonline.org/content/43/2/29.full.

  29. Pavan C, Simonato P, Marini M, Mazzoleni F, Pavan L, Vindigni V. Psychopathologic aspects of body dysmorphic disorder: a literature review. Aesthetic Plast Surg. May 2008;32(3):473-84. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.